Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585247 · ClinicalTrials.gov registry record · NA
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00585247 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 27 participants.
The verdict
NCT00585247, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Port wine stains are red birthmarks that without treatment persist for a lifetime. They are frequently found on the face and can be conspicuous and disfiguring, negatively impacting social interactions for these patients. Treating Port wine stains is difficult. The standard of care is to use laser treatment, but over 80% of patients fail to completely clear despite multiple treatments. The growth of additional blood vessels (angiogenesis) following the Laser treatment is likely an important factor in why these lesions persist despite therapy.
Interventions
- OTHER Placebo
- DRUG Imiquimod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2006-11 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585247
The ClinicalTrials.gov registry entry for NCT00585247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00585247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585247 about?
NCT00585247 is a clinical study titled "Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks". Port wine stains are red birthmarks that without treatment persist for a lifetime. They are frequently found on the face and can be conspicuous and disfiguring, negatively impacting social interactions for these patients. Treating Port wine stains is difficult. The standard of care is to use laser t...
What is the current status of trial NCT00585247?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2006-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00585247?
The interventions under investigation include: Placebo (OTHER), Imiquimod (DRUG).
Who is sponsoring clinical trial NCT00585247?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.